Recurrent immunoglobulin gene translocations identify distinct molecular subtypes of myeloma

Annals of Oncology

Volumn 11, Issue SUPPL. 1, 2000, Pages

  Chesi, M ^a   Kuehl, W M ^b   Bergsagel, P L ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Chromosomal translocations; Cyclin D1; FGFR3; MMSET; Multiple myeloma

Indexed keywords

CYCLIN D1; FIBROBLAST GROWTH FACTOR RECEPTOR; IMMUNOGLOBULIN HEAVY CHAIN; MESSENGER RNA;

CHROMOSOME TRANSLOCATION 11; CHROMOSOME TRANSLOCATION 14; CHROMOSOME TRANSLOCATION 16; CHROMOSOME TRANSLOCATION 21; CHROMOSOME TRANSLOCATION 4; CHROMOSOME TRANSLOCATION 6; CHROMOSOME TRANSLOCATION 8; CONFERENCE PAPER; GENE OVEREXPRESSION; GENE TRANSLOCATION; HUMAN; IMMUNOGLOBULIN GENE; KARYOTYPING; MYELOMA; MYELOMA CELL; PRIORITY JOURNAL;

EID: 0034002023     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/11.suppl_1.S131     Document Type: Conference Paper

References (16)

1. Kyle RA. Monoclonal gammopathy of undetermined significance. In Malpas J, Bergsagel DE, Anderson KC, Kyle RA (eds.): Monoclonal Gammopathy of Undetermined Significance. Oxford: Oxford University Press 1998.
2. Korsmeyer SJ. Chromosomal translocations in lymphoid malignancies reveal novel proto-oncogenes. Annu Rev Immunol 1992; 10: 785-807.
3. Sawyer JR, Waldron JA, Jagannath S and Barlogie B. Cytogenetic findings in 200 patients with multiple-myeloma. Cancer Genet Cytogenet 1995; 82: 41-9.
4. Lai JL, Zandecki M, Mary JY et al. Improved cytogenetics in multiple-myeloma a study of 151 patients including 117 patients at diagnosis. Blood 1995; 85: 2490-7.
5. Bergsagel PL, Chesi MC, Nardini E et al. Promiscuous translocations into IgH switch regions in multiple myeloma. Proc Natl Acad Sci USA 1996; 93: 13931-6.
6. Chesi M, Nardini E, Lim RSC et al. The t(4;14) translocation in myeloma dysregulates both FGFR3 and a novel gene, MMSET, resulting in IgH/MMSET hybrid transcripts. Blood 1998; 92: 3025-34.
7. Chesi M, Nardini E, Brents LA et al. Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3. Nature Genet 1997; 16: 260-5.
8. Chesi M, Bergsagel PL, Shonukan OO et al. Frequent dysregulation of the c-maf protooncogene at 16q23 by translocation to an immunoglobulin locus in multiple myeloma. Blood 1998; 91: 4457-63.
9. Chesi M, Bergsagel PL, Brents LA et al. Dysregulation of cyclin D1 by translocation into an IgH gamma switch region in two multiple myeloma cell lines. Blood 1996; 88: 674-81.
10. Williams ME, Swerdlow SH, Rosenberg CL, Arnold A. Characterization of chromosome 11 translocation breakpoints at the BCL-1 and PRAD1 loci in centrocytic lymphoma. Cancer Res 1992; 52: 5541-4.
11. Nardini E, Bergsagel PL, Chesi MC, Kuehl WM. Dysregulation of cyclin D1 in multiple myeloma. Leuk Lymph (in press).
12. Gabrea A, Bergsagel PL, Chesi M et al. Insertion of excised IgH switch sequences causes overexpression of cyclin D1 in a myeloma tumor cell. Mol Cell 1999; 3: 119-23.
13. Bergsagel PL, Brents LA, Trepel JB, Kuehl WM. Genes expressed selectively in murine and human plasma cell neoplasms. Curr Top Microbiol Immunol 1995; 194: 57-61.
14. Nishizawa M, Kataoka K, Goto N et al. V-maf, a viral oncogene that encodes a 'leucine zipper' motif. Proc Natl Acad Sci USA 1984; 86: 7711-5.
15. Tavormina PL, Shiang R, Thompson LM et al. Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3. Nature Genet 1995; 9: 321-8.
16. Waring PM and Cleary ML. Disruption of a homolog of trithorax by 11q23 translocations: Leukemogenic and transcriptional implications. Curr Top Microbiol Immunol 1997; 220: 1-23.